Skip to Main Content

Login to your account

Show
Forgot password?
Don’t have an account?
Create a Free Account

If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

Cancel
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
Journal of Pediatric Nursing
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
  • Subscribe
  • Claim

Access provided by

Skip menu
  • Articles
    • Cover Image - Journal of Pediatric Nursing: Nursing Care of Children and Families, Volume 70, Issue
    • Latest

      • Articles in Press
      • Issues In Progress
      • Current issue
      • Past Issues
    • Popular Articles

      • Society of Pediatric Nurses Department

        Immunizations – Nursing Interventions to Enhance Vaccination Rates

        • Ann M. Bowling
      • Research Article

        The effect of using maternal voice, white noise, and holding combination interventions on the heel stick sampling

          Apaydin Cirik et al.
      • Editorial

        Infants with colic: Their childhood characteristics

          Neu et al.
    • Latest Articles

      • Research Article
        Open Access

        Barriers and facilitators of family rules and routines during pediatric cancer treatment

          Bates et al.
      • Review Article

        Pedagogical practices developed with children through hospital classes: An integrative literature review

          Ludgério et al.
      • Research Article

        Polycystic ovary syndrome and body image concerns during adolescence

          Saei Ghare Naz et al.
  • Publish
    • For Authors

      • Submit Article
        External Link
      • Guide for Authors
      • Aims & Scope
      • Open Access Information
        External Link
      • Researcher Academy
        External Link
  • Topics
    • Collections

      • Covid-19
      • Instruments and Tools Article Collection
  • About
    • Society

      • SPN
        External Link
      • PENS
        External Link
      • Editorial Board
    • Journal Information

      • Aims & Scope
      • Permissions
      • Reprints
        External Link
      • Abstracting & Indexing
    • Access

      • Subscribe
      • Activate Online Access
  • Contact
    • Contact

      • Contact Us
      • Career Opportunities
        External Link
      • Advertise with Us
        External Link
      • Go to Product Catalog
        External Link
    • Follow Us

      • New Content Alerts
Advanced search
Advanced search

Please enter a term before submitting your search.

Ok
Abstract| Volume 52, P111, May 2020

Download started.

Ok
  • PDF [54 KB]PDF [54 KB]
  • Save
    • Add To Online LibraryPowered ByMendeley
    • Add To My Reading List
    • Export Citation
    • Create Citation Alert
  • Share
    Share on
    • Twitter
    • Facebook
    • Linked In
    • Sina Weibo
    • Email
  • more
    • Reprints
    • Request
  • Top

X-linked Hypophosphatemia (XLH): Burosumab Significantly Improved Rickets and Standing Height Z-Score Compared with Conventional Therapy in Children with XLH

  • Marian Hart
    Marian Hart
      Affiliations
      Indiana University School of Medicine, Indianapolis, IN
      Search for articles by this author
    • Elizabeth Olear
      Elizabeth Olear
        Affiliations
        Yale School of Medicine, New Haven, CT
        Search for articles by this author
      • Angel Chen
        Angel Chen
          Affiliations
          Ultragenyx Pharmaceutical Inc., Novato, CA
          Search for articles by this author
        • Isabel Couto
          Isabel Couto
            Affiliations
            Ultragenyx Pharmaceutical Inc., Novato, CA
            Search for articles by this author
          • Erik A. Imel
            Erik A. Imel
              Affiliations
              Indiana University School of Medicine, Indianapolis, IN
              Search for articles by this author
            • Thomas O. Carpenter
              Thomas O. Carpenter
                Affiliations
                Yale School of Medicine, New Haven, CT
                Search for articles by this author
              • Kathryn Dahir
                Kathryn Dahir
                  Affiliations
                  Vanderbilt University Medical Center, Nashville, TN
                  Search for articles by this author
                • Margo Black
                  Margo Black
                    Affiliations
                    Vanderbilt University Medical Center, Nashville, TN
                    Search for articles by this author
                  DOI:https://doi.org/10.1016/j.pedn.2020.02.025
                  X-linked Hypophosphatemia (XLH): Burosumab Significantly Improved Rickets and Standing Height Z-Score Compared with Conventional Therapy in Children with XLH
                  Previous ArticleSupport Group to Reduce Diabetes Distress in Adolescents with Type 1 Diabetes
                  Next ArticleAn Intersectional Approach to Understanding Potential Health Disparities in Adolescents with a Disorder of Sex Development/Intersex
                      Advertisement
                      Background: In children with X-linked hypophosphatemia (XLH), sometimes called vitamin D resistant rickets, high circulating levels of fibroblast growth factor 23 (FGF23) cause hypophosphatemia with consequent rickets, lower limb deformities, and growth impairment. Conventional therapy requires multiple daily oral phosphate and active vitamin D (Pi/D) doses. Burosumab, a fully human IgG1 monoclonal antibody to FGF23, is U.S. FDA approved for the treatment of XLH in adult and pediatric patients ≥6 months of age.
                      Aims: To compare efficacy and safety of burosumab vs Pi/D in children with XLH.
                      Methods: This was a phase 3, randomized, active-controlled study (CL301; NCT02915705) in 61 children with XLH (1-12 years old). Subjects were randomized 1:1 to open-label subcutaneous burosumab starting at 0.8 mg/kg Q2W or Pi/D (dosing individually tailored by investigator per established guidelines). Eligibility criteria included total Rickets Severity Score (RSS) ≥2.0 and prior treatment with Pi/D. The primary endpoint was the Radiographic Global Impression of Change (RGI-C) Global Score (GS) for rickets at Week 40.
                      Results: Week 40 standing height Z-score change from baseline was significantly greater (p=0.04) in burosumab-treated subjects, with a least square (LS) mean (SE) of 0.16 (0.05) vs 0.03 (0.03) in Pi/D-treated subjects. Week 40 mean (SE) growth velocity was 7.2 (0.4) centimeters/year in burosumab-treated subjects vs 6.1 (0.2) centimeters/year in Pi/D-treated subjects. At Week 40, the RGI-C GS was significantly higher with burosumab vs Pi/D (LS mean ±SE: +1.9 ±0.1 vs +0.8 ±0.1; p<0.0001). More burosumab subjects had substantial healing (RGI-C ≥+2.0), compared with Pi/D subjects (21/29 [72%] vs 2/32 [6%]; p<0.0001). Burosumab was well-tolerated. Adverse events (AEs) of interest, including injection site reactions, hypersensitivity reactions, and gastrointestinal events, were more frequent in the burosumab vs the Pi/D group, all mild to moderate in severity. All subjects completed the study and no subjects discontinued treatment.
                      Conclusions: In this phase 3, randomized, controlled trial, burosumab administration significantly improved rickets and standing height Z-score compared with conventional therapy in children with XLH.

                      Article info

                      Identification

                      DOI: https://doi.org/10.1016/j.pedn.2020.02.025

                      Copyright

                      ScienceDirect

                      Access this article on ScienceDirect
                        Hide CaptionDownloadSee figure in article
                        Toggle Thumbstrip
                          • View Large Image
                          • Download Hi-res image
                          • Download .PPT

                          Related Articles

                            Hide CaptionDownloadSee figure in Article
                            Toggle Thumbstrip
                              • Download Hi-res image
                              • Download .PPT
                              • Home
                              • Articles & Issues
                              • Current Issue
                              • List of Issues
                              • Covid-19 Information
                              • For Authors
                              • Permissions
                              • Researcher Academy
                              • Journal Info
                              • About the Journal
                              • Abstracting/Indexing
                              • Activate Online Access
                              • Career Opportunities
                              • Contact Information
                              • Editorial Board
                              • Info for Advertisers
                              • Pricing
                              • Reprints
                              • New Content Alerts
                              • Subscribe
                              • More Periodicals
                              • Find a Periodical
                              • Go to Product Catalog

                              The content on this site is intended for healthcare professionals.



                              We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
                              Copyright © 2023 Elsevier Inc. except certain content provided by third parties.

                              • Privacy Policy  
                              • Terms and Conditions  
                              • Accessibility  
                              • Help & Contact

                              RELX